Rui, Y., Yao, J., Liu, Y., Long, M., Chen, S., Peng, Y., Liu, T., Long, Y., Meng, L., Chen, M. (2026). An open-label, single-center phase II trial of mitoxantrone hydrochloride liposome combined with programmed death-1 (PD-1) inhibitors for pretreated recurrent or metastatic nasopharyngeal carcinoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.6047